Tara Pidborochynski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tara Pidborochynski has a total of 104 co-authors. Here are the top co-authors by number of shared publications:
- Jennifer Conway
Division of Pediatric Cardiology Stollery Children's Hospital Edmonton Alberta Canada
16 shared publications - Darren H. Freed
Division of Cardiac Surgery, Department of Surgery, University of Alberta, Edmonton, AB, Canada
10 shared publications Holger Buchholz
Department of Cardiac Surgery University of Alberta Edmonton Alberta Canada
8 shared publicationsJennifer Conway
Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada
6 shared publicationsDarren H. Freed
Department of Cardiac Surgery University of Alberta Edmonton Alberta Canada
5 shared publications- Aamir Jeewa
Labatt Family Heart Centre, Division of Pediatric Cardiology, Department of Pediatrics, University of Toronto, Hospital for Sick Children, Toronto, Canada
4 shared publications
Latest Publications
- Open Access
Preservation of pediatric donor hearts via subnormothermic machine perfusion: Comparison to cold storage
- Open Access
- 30 January 2026
- Published by Wiley in Pediatric Transplantation
- Vol. 30 (2) , e70276
Evaluating the Prevalence of Optimal Neurodevelopmental Outcome at 4.5‐Years in Children Previously on Ventricular Assist Device Support
Background: The majority of patients who undergo ventricular assist device (VAD) implant in childhood survive to adulthood. This study examined the neurodevelopmental trajectory post VAD and determined factors associated with non‐optimal outcome. Methods: Patients implanted with a VAD aged < 6 years between 01/2006 and 12/2020, who underwent assessment at 4.5–7‐years of age (and > 6 months post decannulation) with the Complex Pediatric Therapies Follow‐up Program were included in a prospective‐inception‐cohort study. Optimal neurodevelopmental outcome was defined as scores of ≥ 80 on the Wechsler Preschool and Primary Scales of Intelligence, the Beery‐Buktenica Developmental Test of Visual‐Motor Integration and on the Adaptive Behavior Assessment System, in the absence of cerebral palsy, permanent hearing loss, visual impairment, or seizure disorder. Firth multiple regression analysis was used to determine independent factors associated with non‐optimal outcome. Results: A total of 74 patients underwent VAD implant at age < 6 years with neurodevelopmental assessments available for 48/51 patients who survived to testing. Median age at implant was 0.63 years (IQR 0.20, 2.74), 37.5% were female and 39.6% had congenital heart disease. Optimal outcome occurred in 33% of patients. Optimal outcome was associated with female sex [OR 8.03 (95% CI 1.69–56.64) p = 0.007] and implant between 2015 and 2020 [OR 6.59 (95% CI 1.42–42.62) p = 0.016]. Neurological insult sustained pre‐post‐VAD [OR 0.10 (95% CI 0.01–0.63) p = 0.01] was associated with a non‐optimal outcome. Conclusion: Optimal outcome was present in one‐third of patients. Protective factors were female sex and implant between 2015 and 2020. Neurological insult was associated with a non‐optimal outcome.
- 30 January 2026
- Published by Wiley in Pediatric Transplantation
- Vol. 30 (2) , e70276
Open AccessEvaluating the Prevalence of Optimal Neurodevelopmental Outcome at 4.5‐Years in Children Previously on Ventricular Assist Device Support
Background: The majority of patients who undergo ventricular assist device (VAD) implant in childhood survive to adulthood. This study examined the neurodevelopmental trajectory post VAD and determined factors associated with non‐optimal outcome. Methods: Patients implanted with a VAD aged < 6 years between 01/2006 and 12/2020, who underwent assessment at 4.5–7‐years of age (and > 6 months post decannulation) with the Complex Pediatric Therapies Follow‐up Program were included in a prospective‐inception‐cohort study. Optimal neurodevelopmental outcome was defined as scores of ≥ 80 on the Wechsler Preschool and Primary Scales of Intelligence, the Beery‐Buktenica Developmental Test of Visual‐Motor Integration and on the Adaptive Behavior Assessment System, in the absence of cerebral palsy, permanent hearing loss, visual impairment, or seizure disorder. Firth multiple regression analysis was used to determine independent factors associated with non‐optimal outcome. Results: A total of 74 patients underwent VAD implant at age < 6 years with neurodevelopmental assessments available for 48/51 patients who survived to testing. Median age at implant was 0.63 years (IQR 0.20, 2.74), 37.5% were female and 39.6% had congenital heart disease. Optimal outcome occurred in 33% of patients. Optimal outcome was associated with female sex [OR 8.03 (95% CI 1.69–56.64) p = 0.007] and implant between 2015 and 2020 [OR 6.59 (95% CI 1.42–42.62) p = 0.016]. Neurological insult sustained pre‐post‐VAD [OR 0.10 (95% CI 0.01–0.63) p = 0.01] was associated with a non‐optimal outcome. Conclusion: Optimal outcome was present in one‐third of patients. Protective factors were female sex and implant between 2015 and 2020. Neurological insult was associated with a non‐optimal outcome.
- Open Access
- 6 December 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 26 (4) , 850-858
Posttransplant outcomes with prolonged donor heart ischemic time in the pediatric population
- 6 December 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 26 (4) , 850-858
Open AccessPosttransplant outcomes with prolonged donor heart ischemic time in the pediatric population
- Open Access
- 17 June 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (12) , e041384
Evaluating the Prevalence of Optimal Neurodevelopmental Outcome at 2 Years in Children Previously on Ventricular Assist Device Support
Background: Literature reporting neurodevelopmental outcomes for patients who undergo ventricular assist device (VAD) therapy is limited to posttransplant cohorts. This study aims to determine the prevalence of optimal neurodevelopmental outcome and factors associated with nonoptimal outcome in patients implanted with a VAD at ≤15 months of age. Methods: Patients followed by the Complex Pediatric Therapies Follow‐Up Program were included in a prospective‐inception cohort study if born between January 2006 and December 2022 and implanted with a VAD at ≤15 months of age. A modified optimal neurodevelopmental outcome was defined as scores of ≥80 on the Bayley Scales of Infant and Toddler Development and on the Adaptive Behavior Assessment System, and in the absence of cerebral palsy, permanent hearing loss, visual impairment, or seizure disorder. Firth multiple regression analysis was used to determine independent factors associated with nonoptimal outcome. Results: A total of 56 patients underwent VAD implant at ≤15 months with neurodevelopmental assessments available for 39/40 patients who survived to 2 years. The mean age of VAD implant was 5.45 (SD 3.99) months, 69.2% were male, and 38.5% had congenital heart disease. Optimal neurodevelopmental outcome was seen in 25.6% of patients. Neurological insult (OR, 12.34 [95% CI, 1.29–1660.36], P =0.026) was the only independent factor identified associated with nonoptimal outcome. Conclusions: Optimal outcome was demonstrated in one quarter of patients who had a VAD at ≤15 months of age and underwent neurodevelopmental testing at 2 years of age. A potentially modifiable factor of neurological insult was demonstrated as being independently associated with nonoptimal outcome.
- 17 June 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (12) , e041384
Open AccessEvaluating the Prevalence of Optimal Neurodevelopmental Outcome at 2 Years in Children Previously on Ventricular Assist Device Support
Background: Literature reporting neurodevelopmental outcomes for patients who undergo ventricular assist device (VAD) therapy is limited to posttransplant cohorts. This study aims to determine the prevalence of optimal neurodevelopmental outcome and factors associated with nonoptimal outcome in patients implanted with a VAD at ≤15 months of age. Methods: Patients followed by the Complex Pediatric Therapies Follow‐Up Program were included in a prospective‐inception cohort study if born between January 2006 and December 2022 and implanted with a VAD at ≤15 months of age. A modified optimal neurodevelopmental outcome was defined as scores of ≥80 on the Bayley Scales of Infant and Toddler Development and on the Adaptive Behavior Assessment System, and in the absence of cerebral palsy, permanent hearing loss, visual impairment, or seizure disorder. Firth multiple regression analysis was used to determine independent factors associated with nonoptimal outcome. Results: A total of 56 patients underwent VAD implant at ≤15 months with neurodevelopmental assessments available for 39/40 patients who survived to 2 years. The mean age of VAD implant was 5.45 (SD 3.99) months, 69.2% were male, and 38.5% had congenital heart disease. Optimal neurodevelopmental outcome was seen in 25.6% of patients. Neurological insult (OR, 12.34 [95% CI, 1.29–1660.36], P =0.026) was the only independent factor identified associated with nonoptimal outcome. Conclusions: Optimal outcome was demonstrated in one quarter of patients who had a VAD at ≤15 months of age and underwent neurodevelopmental testing at 2 years of age. A potentially modifiable factor of neurological insult was demonstrated as being independently associated with nonoptimal outcome.
- 8 January 2025
- Published by Springer Nature in Pediatric Cardiology
- Vol. 47 (1) , 188-200
Modifiable Health Behaviours in Children with HCM: Lessons from the Heart Health Survey
Obesity factors into hypertrophic cardiomyopathy (HCM)-related risk as a disease modifying environmental factor. Behaviours such as diet and sleep are seldom reported upon in children with HCM. It was our aim to report on these factors in this population. A multicenter cross-sectional study recruited children and teens with HCM aged 10–19 years old from 10 Canadian pediatric care sites. Patient demographics were obtained from review of medical charts. Participants completed the Healthy Hearts Survey, involving 92 questions related to family health history, personal health, smoking, nutrition, and physical or sedentary activity. A cohort of n = 56 patients with median (IQR) age of 15.5 (13.8–16.8) years were enrolled. Over half (53.6%) were classified as overweight or obese based on BMI, with 75% under activity restriction. Consumption of sugar-rich and starchy foods alongside skipping of meals (43.6%) and snacking (87.5%) were reported. A desire to lose weight was prevalent (48.2%) despite general perceptions of good health. Participants slept a median duration of 8 (7.4–9.0) hours on weekdays, however, sleep disturbances were widely reported. A majority (96.4%) reported less than 20 min of exercise per day over the course of the week. Unhealthy patterns regarding diet, sleep, and physical or sedentary activities that associate with cardiovascular risk are present within children with HCM. These habits may worsen disease burden in children with HCM. It is unclear how activity restriction factors into such patterns. There are modifiable lifestyle factors in children with HCM which, if addressed, could positively impact cardiovascular risk.
- 8 January 2025
- Published by Springer Nature in Pediatric Cardiology
- Vol. 47 (1) , 188-200
Modifiable Health Behaviours in Children with HCM: Lessons from the Heart Health Survey
Obesity factors into hypertrophic cardiomyopathy (HCM)-related risk as a disease modifying environmental factor. Behaviours such as diet and sleep are seldom reported upon in children with HCM. It was our aim to report on these factors in this population. A multicenter cross-sectional study recruited children and teens with HCM aged 10–19 years old from 10 Canadian pediatric care sites. Patient demographics were obtained from review of medical charts. Participants completed the Healthy Hearts Survey, involving 92 questions related to family health history, personal health, smoking, nutrition, and physical or sedentary activity. A cohort of n = 56 patients with median (IQR) age of 15.5 (13.8–16.8) years were enrolled. Over half (53.6%) were classified as overweight or obese based on BMI, with 75% under activity restriction. Consumption of sugar-rich and starchy foods alongside skipping of meals (43.6%) and snacking (87.5%) were reported. A desire to lose weight was prevalent (48.2%) despite general perceptions of good health. Participants slept a median duration of 8 (7.4–9.0) hours on weekdays, however, sleep disturbances were widely reported. A majority (96.4%) reported less than 20 min of exercise per day over the course of the week. Unhealthy patterns regarding diet, sleep, and physical or sedentary activities that associate with cardiovascular risk are present within children with HCM. These habits may worsen disease burden in children with HCM. It is unclear how activity restriction factors into such patterns. There are modifiable lifestyle factors in children with HCM which, if addressed, could positively impact cardiovascular risk.
- 19 December 2024
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 71 (8) , 652-659
Subnormothermic Machine Perfusion of Neonatal and Small-Sized Pediatric Donor Hearts
Donor heart machine perfusion enables avoidance of prolonged cold ischemia, however the optimal temperature is yet to be elucidated. Given that maintenance of temperature beyond ambient levels demands significant energy, we sought to determine the suitability of room-temperature perfusion preservation of neonatal/pediatric-sized (5–20 kg) piglet donor hearts. A custom device was fabricated suitable for this purpose, with continuous readout of perfusion pressure, flow rate, temperature, and oxygen saturation. Oxygen delivery was automated to keep saturation above 90%. The perfusate consisted of a 1:1 mix of donor whole blood and modified Krebs–Henseleit solution with albumin. Donor hearts were procured from 5 kg (n = 5), 10 kg (n = 3), and 20 kg (n = 5) piglets, and perfused for 10 hours. Subsequently, 20 kg piglet hearts were transplanted. Hemodynamic stability and echocardiographic measurement of donor heart function were evaluated posttransplant. Perfusate parameters were stable through the perfusion interval. Temperature was consistently 23.8 ± 1.6°C. pH (7.35 ± 0.09) and pO2 (102 ± 29 mm Hg) were steady throughout. Glucose (5.9 ± 1.8 mmol/L) and lactate (2.4 ± 1.5 mmol/L) were metabolized by the heart over the course of perfusion. Transplanted hearts displayed durable hemodynamics and good biventricular function. We conclude that neonatal and pediatric hearts can be safely perfused for extended periods at subnormothermic conditions using blood-based perfusate.
- 19 December 2024
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 71 (8) , 652-659
Subnormothermic Machine Perfusion of Neonatal and Small-Sized Pediatric Donor Hearts
Donor heart machine perfusion enables avoidance of prolonged cold ischemia, however the optimal temperature is yet to be elucidated. Given that maintenance of temperature beyond ambient levels demands significant energy, we sought to determine the suitability of room-temperature perfusion preservation of neonatal/pediatric-sized (5–20 kg) piglet donor hearts. A custom device was fabricated suitable for this purpose, with continuous readout of perfusion pressure, flow rate, temperature, and oxygen saturation. Oxygen delivery was automated to keep saturation above 90%. The perfusate consisted of a 1:1 mix of donor whole blood and modified Krebs–Henseleit solution with albumin. Donor hearts were procured from 5 kg (n = 5), 10 kg (n = 3), and 20 kg (n = 5) piglets, and perfused for 10 hours. Subsequently, 20 kg piglet hearts were transplanted. Hemodynamic stability and echocardiographic measurement of donor heart function were evaluated posttransplant. Perfusate parameters were stable through the perfusion interval. Temperature was consistently 23.8 ± 1.6°C. pH (7.35 ± 0.09) and pO2 (102 ± 29 mm Hg) were steady throughout. Glucose (5.9 ± 1.8 mmol/L) and lactate (2.4 ± 1.5 mmol/L) were metabolized by the heart over the course of perfusion. Transplanted hearts displayed durable hemodynamics and good biventricular function. We conclude that neonatal and pediatric hearts can be safely perfused for extended periods at subnormothermic conditions using blood-based perfusate.
- Open Access
Severe primary graft failure: Are there lasting impacts? Analysis from the PHTS Database
- 10 August 2024
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 43 (11) , 1861-1863
First North American experience with the Berlin Heart EXCOR Active driver
- 10 August 2024
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 43 (11) , 1861-1863
First North American experience with the Berlin Heart EXCOR Active driver
- Open Access
- 18 June 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (12) , e033968
Exploring Health‐Related Quality of Life in Children With Hypertrophic Cardiomyopathy and Relationship to Physical Activity
Background: Hypertrophic cardiomyopathy is a burdensome condition that inflicts both physical and psychological impairment on those with the disease, negatively impacting health‐related quality of life (HRQoL). Given the abundance of evidence suggesting a role of physical activity (PA) in modulating HRQoL in healthy populations of children, we sought to determine the relationship between HRQoL and PA in children diagnosed with hypertrophic cardiomyopathy. Methods and Results: A multicenter prospective observational cohort study was conducted, with patients with hypertrophic cardiomyopathy aged 10 to 19 years being provided a wrist‐worn activity tracker (Fitbit Charge HR) to wear for 14 days. Patients self‐reported on Pediatric Quality of Life 4.0 quality of life inventory items, which were associated with PA metrics following covariate adjustment using linear regression. A total of 56 participants were recruited to the study. The median age at enrollment was 15.5 years (interquartile range, 13.8–16.8), and 16 out of 56 (29%) of the cohort were girls. The cohort reported decreased metrics of physical, psychosocial, and total summary scores compared with health reference populations, with scores comparable with that of published populations with chronic disease. Increased physical HRQoL scores were significantly associated with increased daily steps taken, distance traveled, and flights of stairs climbed. Conclusions: These results show that impaired PA correlates with reduced HRQoL in children with hypertrophic cardiomyopathy, suggesting PA may partially mediate HRQoL in this population.
- 18 June 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (12) , e033968
Open AccessExploring Health‐Related Quality of Life in Children With Hypertrophic Cardiomyopathy and Relationship to Physical Activity
Background: Hypertrophic cardiomyopathy is a burdensome condition that inflicts both physical and psychological impairment on those with the disease, negatively impacting health‐related quality of life (HRQoL). Given the abundance of evidence suggesting a role of physical activity (PA) in modulating HRQoL in healthy populations of children, we sought to determine the relationship between HRQoL and PA in children diagnosed with hypertrophic cardiomyopathy. Methods and Results: A multicenter prospective observational cohort study was conducted, with patients with hypertrophic cardiomyopathy aged 10 to 19 years being provided a wrist‐worn activity tracker (Fitbit Charge HR) to wear for 14 days. Patients self‐reported on Pediatric Quality of Life 4.0 quality of life inventory items, which were associated with PA metrics following covariate adjustment using linear regression. A total of 56 participants were recruited to the study. The median age at enrollment was 15.5 years (interquartile range, 13.8–16.8), and 16 out of 56 (29%) of the cohort were girls. The cohort reported decreased metrics of physical, psychosocial, and total summary scores compared with health reference populations, with scores comparable with that of published populations with chronic disease. Increased physical HRQoL scores were significantly associated with increased daily steps taken, distance traveled, and flights of stairs climbed. Conclusions: These results show that impaired PA correlates with reduced HRQoL in children with hypertrophic cardiomyopathy, suggesting PA may partially mediate HRQoL in this population.
- Open Access
- 17 June 2024
- Published by Wiley in Artificial Organs
- Vol. 48 (10) , 1190-1199
Nutritional status and cannula infections in pediatric patients on ventricular assist device support
Background: Ventricular assist devices (VADs) are used to bridge pediatric patients to heart transplantation. Paracorporeal VADs require the placement of cannulas, which can create an environment for infections. We examined cannula infections in pediatric VAD patients and the role of nutritional status.Methods: This retrospective study (2005–2021) included patients p = 0.05), creatinine (OR = 1.02, p = 0.044), and pre‐albumin (OR = 15.79, p = 0.025), as well as duration of VAD support (OR = 1.01; p = 0.003) were associated with increased odds of developing a cannula infection. There was no difference in the malnutrition parameters between those with and without an infection.Conclusions: Further exploration in a larger cohort is needed to see whether these associations remain and if the incorporation of objective measures of nutritional status at the time of infection are predictive.
- 17 June 2024
- Published by Wiley in Artificial Organs
- Vol. 48 (10) , 1190-1199
Open AccessNutritional status and cannula infections in pediatric patients on ventricular assist device support
Background: Ventricular assist devices (VADs) are used to bridge pediatric patients to heart transplantation. Paracorporeal VADs require the placement of cannulas, which can create an environment for infections. We examined cannula infections in pediatric VAD patients and the role of nutritional status.Methods: This retrospective study (2005–2021) included patients p = 0.05), creatinine (OR = 1.02, p = 0.044), and pre‐albumin (OR = 15.79, p = 0.025), as well as duration of VAD support (OR = 1.01; p = 0.003) were associated with increased odds of developing a cannula infection. There was no difference in the malnutrition parameters between those with and without an infection.Conclusions: Further exploration in a larger cohort is needed to see whether these associations remain and if the incorporation of objective measures of nutritional status at the time of infection are predictive.